Since she officially joined the O club – that’s Oscar winners, get your mind out of the gutter – in 2013, Jennifer Lawrence has stacked her resume with interesting, headline-grabbing projects.
She’s teamed up with David O. Russell two further times (earning her another handful of Oscar nominations), she’s joined projects like Stephen Spielberg’s biopic of Pulitzer winning photojournalist Lynsey Addario, written a movie with her BFF Amy Schumer, moved into producing (she’ll be behind the camera as well as in front of it in Marita, the biopic of Fidel Castro’s mistress Martia Lorenz) and she’s just wrapped filming on one of the buzziest films of next year: the sci-fi romance flick Passengers with Chris Pratt.
Now, she’s just signed on to what promises to be her most controversial film yet: a biopic of businesswoman Elizabeth Holmes, the one-time youngest self-made female billionaire, The Hollywood Reporter reports. Adam Mckay – he of The Big Short fame – is attached to write, direct and produce.
You might have heard of Holmes, 32, who has been in the headlines recently thanks to the controversy haunting her tech startup Theranos. It’s a blood-testing business, which claimed to revolutionise and streamline blood testing with just a single pin-prick test. Accolades and funding flooded in, and the company was valued at $9 billion. Holmes herself was worth a cool $4.5 billion, a ranking that earned her the title of Forbes’ youngest self-made female billionare last year. She appeared on the cover of the New York Times Style magazine and in profiles in business magazines Fortune, Inc. and Forbes.
If this all sounds too good to be true to you, then you’re right. This month, Forbes revalued Holmes and her company’s worth to just $0, after claims that the company’s testing is inaccurate.
The fall from grace has been swift and spectacular. All things that make for excellent film fodder. File this under: Can’t. Wait.
Related stories
Native ad body.
Native ad body.
Native ad body.
